GPTHEALTH · Health Care · 2026-08-21

GPT Healthcare Ltd

5.3★ FairSolid +5.8Stage 2 · wk 10In scan: Pullback Hunter · Prop ScanMARKET: BULL RISING · 2026-08-21
₹150.6
-0.51% today
₹1,236 Cr · Small cap
About this companyHealth Care· Hospitals & Diagnostic Centres
Expand ▾

GPT Healthcare Limited owns and operates a chain of multispecialty hospitals under the ILS Hospitals brand name in India. The company offers healthcare services, including internal medicine and diabetology; nephrology, such as renal transplants; laparoscopic and general surgery; gynecology and obstetrics; critical care; gastroenterology; orthopedics and joint replacement; interventional cardiology; neurology; neurosurgery; pediatrics; neonatology; robotic-assisted surgery; bariatric surgery; hematology; psychology; dermatology; and ENT services. It also operates clinics and pharmacies; provides academic and diagnostic services; and sale of pharmaceutical products. The company was incorporated in 1989 and is based in Kolkata, India. GPT Healthcare Limited operates as a subsidiary of GPT Sons Pvt. Ltd.

Visit company website →
P/E (TTM)
27.2
Forward 14.0
Earnings Growth (YoY)
+13.7%
Revenue +24.6%
ROE
+16.3%
Profit margin +8.9%
Dividend Yield
2.16%
P/B 4.5
vs 52W High
-11.6%
₹115.3 lo₹170.5 hi
11.6% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 10
1w13w26w
Week 10 — early Stage 2, building
How long this stock has been in Stage 2. The sweet spot is typically 13–26 weeks — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
7.1%
200 DMA: ₹140.6 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.49x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
→
MA20 flat · +0.2% vs MA50 +4.2%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
55.5%
20d Δ
+3.9pp
1M return
+2.7%
3M return
+9.6%
Sector Stage-2 % · last 20 days
This stock ranks #74 of 84 Stage 2 stocks in Health Care by RS. Lagging sector peers.
Industry
Hospitals & Diagnostic Centres
↓ Peaking
Stage 2%
55.6%
20d Δ
-7.4pp
1M return
-2.8%
3M return
+2.0%
Industry Stage-2 % · last 20 days
Ranks #13 of 15 Stage 2 stocks in this industry.
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2024-02-29 → 2026-08-21
S? 42w
S4 11w
S4 29w
2024-02-292026-08-21
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 42w → S3 1w → S2 7w → S3 1w → S4 11w → S1 6w → S4 4w → S1 5w → S2 4w → S3 2w → S4 29w → S1 6w → S2 10w current
Total tracked: 128 weeks across 13 stage runs.
1M
-3.9%
3M
+7.6%
6M
+16.5%
YTD
+10.4%
1Y
-7.2%
Scan Membership
Pullback Hunter
Latest: 2026-08-14
Prop Scan
Latest: 2026-08-14
60 appearances in last 60 days. First seen: 2026-06-29.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-21S2
Wk 10 · Vol —x
2026-08-20S2
Wk 10 · Vol —x
2026-08-19S2
Wk 10 · Vol —x
2026-08-18S2
Wk 10 · Vol —x
2026-08-17S2
Wk 10 · Vol —x
2026-08-14S2
Wk 9 · Vol —x
2026-08-13S2
Wk 9 · Vol —x
2026-08-12S2
Wk 9 · Vol —x
2026-08-11S2
Wk 9 · Vol —x
2026-08-10S2
Wk 9 · Vol —x
2026-08-07S2
Wk 8 · Vol —x
2026-08-06S2
Wk 8 · Vol —x
Sector Peers — Stage 2All →
NEULANDLAB
wk 12 · -1.5% from hi
9.0
ALIVUS
wk 19 · -3.4% from hi
9.0
DIVISLAB
wk 14 · -0.0% from hi
8.8
SAILIFE
wk 25 · -1.0% from hi
8.8
SHILPAMED
wk 15 · -0.9% from hi
8.6
Moving averages & range
50 DMA
₹155.2
200 DMA
₹140.6
52W High
₹170.5
52W Low
₹115.3
5D Low
₹150.6
Resistance levels (recent highs)
20d High
₹170.5
60d High
₹170.5
120d High
₹170.5
250d High
₹170.5
Next resistance
+13.2%
to 20d High

All analytics based on EOD data. Data as of 2026-08-21. Past data patterns are not indicative of future results. This page is a data analytics tool only.